MATRIXZUSAMMENSETZUNG AUF ISOPRENBASIS

European patent · EP4225255 · In force

Register entry

Publication number
EP4225255
Application number
EP21782768
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Oct 7, 2021
Published
Aug 16, 2023
Granted
Aug 27, 2025
Protection ends at the latest
Oct 6, 2041
Next annual fee due
Oct 31, 2027
IPC classes
A61K 6/54 (2020.01)
A61K 6/69 (2020.01)
A61K 6/76 (2020.01)
Priority
EP 20382886 08.10.2020
PCT application
PCT/EP2021/077676 07.10.2021
PCT publication
WO2022/074110 14.04.2022
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.10.2026 → 31.10.2027

    Published in Swissreg on 01.11.2026

  2. Jul 8, 2026

    Change

    Published in Swissreg on 08.07.2026

  3. Dec 8, 2025

    Agent entered

    Representative
    BOVARD AG, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 08.12.2025

  4. Nov 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.10.2025 → 31.10.2026

    Published in Swissreg on 01.11.2025

  5. Aug 27, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 27.08.2025

Parties

Inventor

PÉREZ ANTOÑANZAS, Román

08850 GAVÀ, ES

GIORDANO, Ana Barbara

08012 BARCELONA, ES

DURÁN-SINDREU TEROL, Fernando

08024 BARCELONA, ES

GONZÁLEZ SÁNCHEZ, José Antonio

08173 SANT CUGAT DEL VALLÈS, ES

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.